Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis.

Annals of the Rheumatic Diseases
V P van HalmM T Nurmohamed

Abstract

Cardiovascular mortality is increased in patients with ankylosing spondylitis. A possible explanation might be a more prevalent atherogenic lipid profile in patients with ankylosing spondylitis than in the general population. It has been postulated that inflammation deteriorates the lipid profile, thereby increasing cardiovascular risk. To explore the association between disease activity and lipid profile in patients with ankylosing spondylitis. Disease activity parameters for ankylosing spondylitis and lipid levels (total cholesterol, high-density lipoprotein cholesterol (HDLc) and triglycerides) were measured in 45 patients with ankylosing spondylitis for 6 months after starting treatment with leflunomide or placebo. Findings in this treatment group were compared with those in 10 patients with ankylosing spondylitis treated with etanercept. A specialised regression model, adjusting for repeated measurements, age and sex, was used to assess the influence of the disease activity variables on the lipid levels. Multilevel regression analyses showed significant associations between disease activity parameters and lipid levels-for instance, an increase of 30 mm at the end of the first hour in erythrocyte sedimentation rate was asso...Continue Reading

References

Sep 15, 1977·The New England Journal of Medicine·E P RadfordP G Smith
Jan 1, 1980·The Practitioner·S M Doherty, D A Yates
Jan 1, 1996·British Journal of Rheumatology·S D JonesA Calin
Jan 14, 1999·The New England Journal of Medicine·R Ross
Jul 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Johannes Hulthe, Björn Fagerberg
Aug 7, 2002·International Journal of Cardiology·Joseph Walsmith, Ronenn Roubenoff
Oct 11, 2002·Statistics in Medicine·Harvey GoldsteinJon Rasbash
Nov 7, 2002·The American Journal of Cardiology·Daniel J Rader
Mar 5, 2003·The American Journal of Cardiology·Dennis L SprecherErnst J Schaefer
Sep 4, 2004·Annals of the Rheumatic Diseases·A CalinS Fatenejad
May 20, 2005·Annals of the Rheumatic Diseases·J C van DenderenI E van der Horst-Bruinsma

❮ Previous
Next ❯

Citations

Mar 30, 2010·Rheumatology International·V F Azevedo, R Pecoits-Filho
Dec 25, 2012·Zeitschrift für Rheumatologie·A InanirH Kadi
Jan 13, 2010·Immunology and Cell Biology·Bi-lian YuShui-ping Zhao
Jun 7, 2007·Current Opinion in Rheumatology·Sylvia Heeneman, Mat J A P Daemen
Feb 1, 2010·Therapeutic Advances in Musculoskeletal Disease·Laura C CoatesPaul Emery
Oct 19, 2013·Clinical Rheumatology·Björn SundströmSolveig Wållberg-Jonsson
Jul 22, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Sylvain MathieuMartin Soubrier
Sep 27, 2008·Current Rheumatology Reports·Walter P Maksymowych
Dec 22, 2009·Joint, Bone, Spine : Revue Du Rhumatisme·Sylvain MathieuMartin Soubrier
Apr 9, 2008·Seminars in Arthritis and Rheumatism·George Steiner, Murray B Urowitz
Oct 5, 2010·Arthritis Care & Research·Sylvain MathieuMartin Soubrier
Mar 17, 2015·Clinical Rheumatology·Nidhi GargAshit Syngle
May 11, 2015·Clinical Rheumatology·Lianne S Gensler
Jun 18, 2016·Zeitschrift für Rheumatologie·A KucukM Kayrak
Jan 2, 2008·Seminars in Arthritis and Rheumatism·John C Davis, Philip J Mease
Nov 5, 2016·Clinical Hemorheology and Microcirculation·Ewa KlimekTomasz K Grodzicki
Jan 19, 2017·Anais Brasileiros De Dermatologia·André Vicente Esteves de CarvalhoLuana Pizarro Meneghello
Jan 11, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Michael NurmohamedPaola Accossato
Sep 4, 2015·The Journal of Rheumatology·Sjoerd C HeslingaMichael T Nurmohamed
Feb 4, 2014·The Journal of Rheumatology·Andrzej SurdackiTomasz K Grodzicki
Dec 4, 2009·The Journal of Rheumatology·Mike J L PetersMichael T Nurmohamed
Jan 18, 2011·The Journal of Rheumatology·Nóra BodnárSándor Szántó
Aug 31, 2017·Clinical Reviews in Allergy & Immunology·Santos CastañedaMiguel A González-Gay
Nov 30, 2019·Expert Review of Clinical Immunology·Santos CastañedaMiguel A González-Gay
Nov 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takao KimuraFumikazu Okajima
Jun 22, 2021·Frontiers in Immunology·Giulia FuresiMartina Rauner
Aug 12, 2021·Therapeutic Advances in Musculoskeletal Disease·Shirley Chiu Wai ChanHo Yin Chung

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.